Article
Leukotriene C4 synthase and ischemic cardiovascular disease and obstructive pulmonary disease in 13,000 individuals.
Journal of molecular and cellular cardiology - 1 Apr 2009
Freiberg Jacob J, Dahl Morten, Tybjaerg-Hansen Anne, Grande Peer, Nordestgaard Børge G
Abstract excerpt
Ischemic cardiovascular disease and obstructive pulmonary disease involve inflammation. Leukotrienes may be important pro-inflammatory mediators. We tested the hypothesis that the (-1072)G > A and (-444)A > C promoter polymorphisms of leukotriene C4 synthase confer risk of transient ischemic attack (TIA), ischemic stroke, ischemic heart disease (IHD), asthma, and chronic obstructive pulmonary disease (COPD). We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
